# Marker Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 20, 2025

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-20
- Accepted by EDGAR: Aug 20, 2025, 20:58 ET
- Period: not reported
- Accession: 0001104659-25-080957
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465925080957/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465925080957/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465925080957/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-080957. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.